Clinical Trial Results:
A randomized, double-blind, placebo-controlled, single-dose, parallel-group comparison of the analgesic efficacy, safety and local tolerability of intravenous paracetamol 1% solution Bioren (test), Perfalgan® 1% (reference), and placebo in a post-surgical dental pain model
Summary
|
|
EudraCT number |
2005-005575-14 |
Trial protocol |
GB |
Global completion date |
01 Oct 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Apr 2018
|
First version publication date |
21 Apr 2018
|
Other versions |
|
Summary report(s) |
R-01270-A015 EudraCT Synopsis_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.